Downloads
Revenue

Description

“爱病理”,是一款用心为病理人打造的有价值的病理工具,现拥有病例讨论、课程、答题、咨询、质控、读片会等功能,希望可以用科技帮助医生。
-【个性首页】根据感兴趣的亚专科领域,定制个性化首页,全国病理同行分享的精彩病例,每日都可以在首页发现。
-【投票评论】多种病例讨论形式,分享诊断建议收获认同感谢,还能参与投票,数据化呈现同行观点。
-【优质内容】知名医院专家的专栏文章,定期筛选优质病例,都持续更新在发现页。
-【互动课程】开设系列教学课程,跟随大咖的思路阅片,和大咖实时互动,还能参与答题,在线课堂测评立即反馈学 习效果。
-【实时呼叫】遇到疑难病例时,不仅可以创建病例咨询专家,还能配合实视目镜,远程呼叫病理同行,对方即时看到本地镜下视野,带着手机就能实时咨询,更加方便灵活。
Hide Show More...

In-Apps

3病理币
$990.00
6病理币
$990.00
25病理币
$3.99
30病理币
$4.99
50病理币
$6.99
98病理币
$14.99

Screenshots

爱病理 FAQ

  • Is 爱病理 free?

    Yes, 爱病理 is free to download, however it contains in-app purchases or subscription offerings.

  • Is 爱病理 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 爱病理 cost?

    爱病理 has several in-app purchases/subscriptions, the average in-app price is $335.16.

  • What is 爱病理 revenue?

    To get estimated revenue of 爱病理 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Chile yet.
Ratings History

爱病理 Reviews

大爱

爱唱歌的羊 on

China

我在APP第一条评论就送给这个让我如此感激感恩的爱病理APP了。真心觉得非常好,彭老师的讲课如此清晰和精彩,膜拜了。第一次听课,也会一直关注。祝愿爱病理发展壮大,越来越好✌🏻✌🏻✌🏻

很实用,病理人自己的App

蓝天白云肥肥 on

China

遇到不懂不明白的都会去提问,每天花点时间看病例,还能积累知识,非常实用的,点赞

之前遇到一病人吞咽困难,院里讨论无果,后来发了切片到这里,得到了某院主任的回答,在此感谢🙏

yi来了 on

China

之前遇到一病人吞咽困难,院里讨论无果,后来发了切片到这里,得到了某院主任的回答,在此感谢🙏

病理人的app

achillesctf on

China

总算有一款可以病理人自己来解决问题的app了,好用,还能学到东西,每天都上去看看

实用

平子儿 on

China

很好的学习平台,无广告,学术氛围浓厚,真正属于病理人的app

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Keywords

爱病理 Competitors

Name
施强健康
医路有伴-专业的医疗外科教学平台
肿瘤指南者医生端
治趣- 临床医学病例模拟诊疗平台
CSP
梅斯医生 — 临床必备工具
医学电子书包-2021年医学资格证考试题库
最新医学资格证考试题库
华夏病理
华夏病理云诊断平台
免疫组化助手

爱病理 Installs

Last 30 days

爱病理 Revenue

Last 30 days

爱病理 Revenue and Downloads

Gain valuable insights into 爱病理 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.